Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cytophage Technologies Ltd V.CYTO

Alternate Symbol(s):  CPTCF

Cytophage Technologies Ltd. is a Canadian biotechnology company. The Company uses advanced molecular genetic techniques and synthetic biology to create bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:CYTO)

Cytophage Reports Q1 Financials and Provides Business Update

TheNewsWire 2 days ago

Cytophage Strengthens Board of Directors

TheNewsWire 5 days ago

Cytophage Announces Fiscal Year End 2023 Results

TheNewsWire April 30, 2024

Cytophage Appoints New Board Director

TheNewsWire April 16, 2024

Cytophage Provides Update on Bacteriophage Human Trial at The Ottawa Hospital

TheNewsWire April 2, 2024

Cytophage Provides Bacteriophages for Landmark Treatment of Joint Replacement Infection in Canada

TheNewsWire March 1, 2024

Cytophage Update on Upcoming Product for Egg Production in Canada

TheNewsWire February 12, 2024

Cytophage Technologies Ltd. Completes Reverse Takeover Transaction of Cuspis Capital III Ltd.

TheNewsWire February 2, 2024

Cuspis Capital III Ltd. Announces Filing of Filing Statement with Respect to its Qualifying Transaction

TheNewsWire February 2, 2024
View More News ››

Opinion & Analysis (TSXV:CYTO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:CYTO)

RE:RE:RE:Phages work

Oh ic.  nice.  buying the dips
a2bman - 2 days ago

RE:RE:Phages work

Oviphage An application for regulatory approval in the United States has been submitted and a similar regulatory approval submission for...
Speedmaster2022 - 5 days ago

RE:Phages work

What us news, like a listing?  a little small, no?
a2bman - 5 days ago

Phages work

This'll bust out on U.S. news.
Speedmaster2022 - 8 days ago

RE:Avian flu in cows milk

The Lancet Infectious Disease journal reported in its review of 59 clinical studies between 2000 and 2021, that of 1,904 patients with...
a2bman - 9 days ago

Avian flu in cows milk

One more reason to use co's livestock product.   https://www.cbsnews.com/news/bird-flu-raw-milk-unpasteurized-dairy/
lscfa - 10 days ago
View more Bullboard ››

Revive Therapeutics Ltd.

Revive Therapeutics Ltd.

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of ...
View More »